Page last updated: 2024-09-05

cp 424391 and Body Weight

cp 424391 has been researched along with Body Weight in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Ceron-Romero, N; Heinen, E; Sanmartin, K; Taofeek, N; Thomas, A; Verghese, M; Vizcarra, JA; Vroonland, E1
Rhodes, L; Smith, RG; Zollers, B1
Heinen, E; Huebner, M; Rhodes, L; Wofford, JA; Zollers, B1
Heinen, E; Rhodes, L; Zollers, B1
Carpino, PA; Chidsey-Frink, K; DaSilva-Jardine, PA; Lefker, BA; Lu, B; MacLean, DB; Mullins, MA; Nettleton, DO; Ng, O; Nickerson, DF; Pan, LC; Pettersen, JC; Pirie, CM; Ragan, JA; Tess, DA; Thompson, DD; Toler, SM1
Black, SC; Ellery, SS; MacAndrew, JT; Pan, LC; Parry, MA1

Trials

4 trial(s) available for cp 424391 and Body Weight

ArticleYear
Capromorelin, a ghrelin receptor agonist, increases feed intake and body weight gain in broiler chickens (Gallus gallus domesticus).
    Poultry science, 2021, Volume: 100, Issue:8

    Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Body Weight; Chickens; Diet; Eating; Male; Piperidines; Pyrazoles; Receptors, Ghrelin; Weight Gain

2021
Capromorelin increases food consumption, body weight, growth hormone, and sustained insulin-like growth factor 1 concentrations when administered to healthy adult Beagle dogs.
    Journal of veterinary pharmacology and therapeutics, 2017, Volume: 40, Issue:2

    Topics: Animals; Body Weight; Dogs; Dose-Response Relationship, Drug; Eating; Growth Hormone; Hydrocortisone; Insulin-Like Growth Factor I; Piperidines; Pyrazoles

2017
A Prospective, Randomized, Masked, Placebo-Controlled Clinical Study of Capromorelin in Dogs with Reduced Appetite.
    Journal of veterinary internal medicine, 2016, Volume: 30, Issue:6

    Topics: Animals; Appetite; Appetite Stimulants; Body Weight; Dogs; Female; Male; Piperidines; Prospective Studies; Pyrazoles; Receptors, Ghrelin

2016
Capromorelin oral solution (ENTYCE®) increases food consumption and body weight when administered for 4 consecutive days to healthy adult Beagle dogs in a randomized, masked, placebo controlled study.
    BMC veterinary research, 2017, Jan-05, Volume: 13, Issue:1

    Topics: Animals; Appetite Stimulants; Body Weight; Cross-Over Studies; Dogs; Eating; Female; Male; Piperidines; Pyrazoles

2017

Other Studies

2 other study(ies) available for cp 424391 and Body Weight

ArticleYear
Preclinical pharmacology of CP-424,391, an orally active pyrazolinone-piperidine [correction of pyrazolidinone-piperidine] growth hormone secretagogue.
    Endocrine, 2001, Volume: 14, Issue:1

    Topics: Administration, Oral; Adrenocorticotropic Hormone; Animals; Body Weight; Calcium; Cells, Cultured; Dogs; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Hydrocortisone; Models, Animal; Molecular Structure; Oligopeptides; Peptides; Piperidines; Pituitary Gland, Anterior; Pyrazoles; Rats; Rats, Sprague-Dawley; Rats, Wistar; Somatostatin; Time Factors

2001
Efficacy of a growth hormone-releasing peptide mimetic in cardiac ischemia/reperfusion injury.
    European journal of pharmacology, 2001, Dec-07, Volume: 432, Issue:2-3

    Topics: Animals; Body Weight; Dose-Response Relationship, Drug; Growth Hormone; Heart Ventricles; Hemodynamics; Insulin-Like Growth Factor I; Male; Myocardial Infarction; Piperidines; Pyrazoles; Rabbits; Reperfusion Injury; Time Factors; Treatment Outcome

2001